Cost Effectiveness of Sorafenib Versus SBRT for Advanced Hepatocellular Carcinoma
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1600
https://www.valueinhealthjournal.com/article/S1098-3015(16)01668-5/fulltext
Title :
Cost Effectiveness of Sorafenib Versus SBRT for Advanced Hepatocellular Carcinoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01668-5&doi=10.1016/j.jval.2016.03.1600
First page :
A152
Section Title :
Cancer - Cost Studies
Open access? :
No
Section Order :
322